--- title: "Cencora: Competitors" description: "Cencora compared with companies that share its SEC industry classification: revenue, growth and margins from SEC filings, and how the peer group is chosen." canonical: https://www.getswoopr.com/stocks/companies/cencora/competitors/ source: "Swoopr Investment: https://www.getswoopr.com" --- # Cencora: Competitors & Industry Structure ## Direct Answer SEC EDGAR classifies Cencora under SIC code 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Among Swoopr's S&P 500 Equal Weight companies, 6 others share that classification; by latest reported revenue, Cencora ranks 2 of 7. A filing classification is a starting point: a company's real competitors depend on its segments, which its 10-K describes. ## How Does Cencora Compare With Its Peers? | Company | Revenue (latest FY) | Revenue growth | Operating margin | Net margin | | --- | --- | --- | --- | --- | | [McKesson Corporation (MCK)](https://www.getswoopr.com/stocks/companies/mckesson-corporation/) | $403 billion FY2026 | 12.4% | 1.5% | 1.2% | | **Cencora (COR)** | $321 billion FY2025 | 9.3% | 0.8% | 0.5% | | [Cardinal Health (CAH)](https://www.getswoopr.com/stocks/companies/cardinal-health/) | $223 billion FY2025 | -1.9% | 1.0% | 0.7% | | [Nu Skin Enterprises Inc. (NUS)](https://www.getswoopr.com/stocks/companies/nu-skin-enterprises-inc/) | $1.5 billion FY2025 | -14.3% | 4.4% | 10.8% | | [Cosmos Health Inc. (COSM)](https://www.getswoopr.com/stocks/companies/cosmos-health-inc/) | $65 million FY2025 | 19.9% | -25.6% | -29.3% | | [DataMeds AI Inc. (MEDS)](https://www.getswoopr.com/stocks/companies/datameds-ai-inc/) | $23 million FY2025 | 28.7% | -401.7% | -433.9% | | [HWH International Inc. (HWH)](https://www.getswoopr.com/stocks/companies/hwh-international-inc/) | $866,926 FY2025 | -30.8% | n/a | -303.4% | Revenue growth compares each company's latest fiscal year with the one before. Fiscal years do not always end on the same date, so treat close comparisons with care. ![Bar chart of operating margin for Cencora and 5 peers: McKesson Corporation (MCK) 1.5%, Cencora (COR) 0.8%, Cardinal Health (CAH) 1.0%, Nu Skin Enterprises Inc. (NUS) 4.4%, Cosmos Health Inc. (COSM) -25.6%, DataMeds AI Inc. (MEDS) -401.7%.](https://www.getswoopr.com/images/charts/cencora-competitors-peer-margins.webp) *Operating margin of Cencora against companies sharing its SEC industry classification, from the table above. Select the chart to open it full size.* ## How Does Cencora Rank Among All SEC Filers in Its Industry Code? 7 companies with annual reports in Swoopr's SEC dataset share SIC code 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries), a wider group than the S&P 500 Equal Weight companies above. Ranks run from 1 (highest) and use each company's latest fiscal year, in U.S. dollars. | Measure | Cencora | Median of filers | Rank | | --- | --- | --- | --- | | Revenue | $321 billion | $1.5 billion | 2 of 7 | | Revenue growth | 9.3% | 9.3% | 4 of 7 | | Operating margin | 0.8% | 0.9% | 4 of 6 | | Net margin | 0.5% | 0.5% | 4 of 7 | A SIC code reflects the filer's main business as the SEC records it, so the group mixes companies of very different size; the median is a better guide than the average, and a rank near the top by revenue says nothing about quality. ## Where These Numbers Come From Every figure on this page is a value Cencora reported in its own SEC filings, read from the SEC's XBRL data (accession 0001140859-26-000012 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary. Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation. ## Frequently Asked Questions ### Who are Cencora's competitors? Companies sharing Cencora's SEC classification (SIC code 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries)) include McKesson Corporation (MCK), Cardinal Health (CAH), Nu Skin Enterprises Inc. (NUS), Cosmos Health Inc. (COSM), DataMeds AI Inc. (MEDS). Its 10-K names the competitors it considers most relevant. ### How does Cencora compare with its peers on margins? Cencora's fiscal 2025 operating margin was 0.8%, against a peer median of 1.0%. ### How are these peers chosen? By the SEC Standard Industrial Classification code each company files under, within Swoopr's S&P 500 Equal Weight company set, falling back to the two-digit major group when fewer than two companies share the exact code. Classification codes are broad, so read the peer list as a screen, not a verdict. ### How does Cencora rank among all companies in its SEC industry? Among 7 SEC filers under SIC code 5122, Cencora ranks 2 by latest revenue, and 4 of 6 by operating margin (0.8% against a median of 0.9%). ## References - [SEC EDGAR: Cencora, Inc. Form 10-K filed November 25, 2025](https://www.sec.gov/Archives/edgar/data/1140859/000114085925000131/cor-20250930.htm) - [SEC EDGAR: Cencora, Inc. annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1140859&type=10-K) - [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces) ## Related Pages - [Cencora company dossier](https://www.getswoopr.com/stocks/companies/cencora/) - [Cencora financial metrics](https://www.getswoopr.com/stocks/companies/cencora/metrics/) - [Cencora financial risk indicators](https://www.getswoopr.com/stocks/companies/cencora/risks/) - [Cencora peer comparison](https://www.getswoopr.com/stocks/companies/cencora/competitors/) - [Cencora business model and revenue mix](https://www.getswoopr.com/stocks/companies/cencora/business-model/) - [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/) **[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)** Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).